Transaction · 0001829126-26-011084

Svlsf VI, LLC

SVLSF VI, LLC, 10%, reported a transaction classified as unknown at TRex Bio, Inc. involving 475411.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2264354.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code C10%
TRXBTRex Bio, Inc.
Trade date
Oct 13, 2026
Filing date
Oct 13, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded475k$0.00 per share
Holdings after2.26MIndirect · By SV Life Sciences Fund VI, L.P.
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TRXB price since this filing

Daily closing prices, with the filing date and available return windows
TRXB · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago +3.2%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code C
Identifier
0001829126-26-011084
Common Stock
Transaction date
Oct 13, 2026
Filed Oct 13, 2026, 08:30 PM · 0d delay
Shares
475,411 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
2,264,354 sh
Indirect · By SV Life Sciences Fund VI, L.P.
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    The shares are held directly by SV Life Sciences Fund VI, L.P. ("SV Fund VI"). SV Life Sciences Fund VI (GP), L.P. (the "GP LP") is the general partner of SV Fund VI, and SVLSF VI, LLC ("SVLSF") is th…

  2. F2

    The shares are held directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Strategic Partners VI"). GP LP is the general partner of SV Strategic Partners VI, and SVLSF is the general partn…

  3. F3

    The shares are held directly by SV Trex Coinvestment, L.P. ("SV Coinvestment"). GP LP is the general partner of SV Coinvestment, and SVLSF is the general partner of GP LP. Investment and voting decisi…

  4. F4

    On October 13, 2026, 3.8649 shares of preferred stock automatically converted into one share of common stock upon the closing of the issuer's initial public offering, for no additional consideration.…

  5. F5

    Represents shares purchased by SV Fund VI in the issuer's initial public offering.

  6. F6

    Represents shares purchased by SV Strategic Partners VI in the issuer's initial public offering.

Original filing · 0001829126-26-011084
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TRXB